long intergenic non-protein coding RNA 2043Genealiases: []
Q-omics provides the consensus-scored LINC02043 profile across patient tissues and cancer cell-line models. LINC02043 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, LINC02043 is differentially expressed in 10, with the highest sampling consensus in HNSC. Additionally, LINC02043 RNA expression shows 14,769 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight COAD, HNSC, and LSCC as cancer lineages where LINC02043 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02043 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02043 survival associations across molecular data types. LINC02043 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02043 RNA expression–survival associations across cancer types. High LINC02043 expression shows unfavorable associations in COAD, KIRP, UCEC, ACC, KIRC and THYM. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify COAD as the clearest survival context for LINC02043 RNA expression.
This table summarizes LINC02043 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02043. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02043 shows higher tumor expression in HNSC, COAD, LUAD, LIHC, LUSC and UCEC. The HNSC box plot shows higher LINC02043 RNA expression in tumor versus normal tissue (log2 FC = +0.389, t-test p < 0.001).
This table shows molecular features associated with LINC02043 in patient tissues and cancer cell lines. In patient samples, LINC02043 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
